Use access key #2 to skip to page content.
$0.25 0.01 (4.00%)
11/21/2008 2:48 PM

Genta, Inc. (GNTA)

CAPS Rating:
No stars

A biopharmaceutical company engaged in pharmaceutical (drug) research and development and dedicated to the identification, development and commercialization of novel drugs for the treatment of cancer and related diseases.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

Ticker Not Ratable

GNTA doesn't currently meet the $100M market cap / $1.50 stock price minimum. (Learn More)

What the Community Thinks

Total Members

2 Outperforms
2 Underperforms
 

All-Stars

0 Outperforms
2 Underperforms
 

Members bullish on GNTA are also bullish on:

Members bearish on GNTA are also bearish on:

Ticker Tags

Micro Cap (5043), Biotechnology (230)
Suggest a tag

Genta, Inc. At A Glance

Current Price: $0.25
Last Trade Time: 11/21/2008 2:48 PM
Open: $0.25
Previous Close: $0.25
Daily Range: $0.25 - $0.29
52-Week Range: $0.09 - $0.87
Volume: 73,321
Market Cap: $16.90M
P/E Ratio: 0.00
Compare Our Special Broker Offers!

Stock Trends

GNTA VS S&P 500 (SPY)

News & Discussion Boards

Other News Headlines for GNTA

More Headlines...

Top Bull Pitch

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches below!

Top Bear Pitch

Recs

1

Genta, Inc. (GNTA)

Avatar mansloth (97.53) Submitted: 8/31/06 9:13 PM

This company's technology is suspect. Plus, they should be out of cash within the next year, at which point they will simply offer more stock to fill the coffers, whilst their products dwindle in clinicals. Should've shorted this sooner......

Replies: 0 | Reply | Permalink

CAPS Members

picks per page. CHANGE

Results 1 - 1 of 1  

Recs

1

 (GNTA)

Avatar mansloth (97.53) Submitted: 8/31/06 9:13 PM : Underperform Start Price: $9.36 GNTA Score: 55.16

This company's technology is suspect. Plus, they should be out of cash within the next year, at which point they will simply offer more stock to fill the coffers, whilst their products dwindle in clinicals. Should've shorted this sooner......

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 1 of 1  

Wall Street

There are no Wall Street tracker picks.

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

Sponsored Links